Subscribe to Drug Discovery & Development Articles
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

The Cystic Fibrosis Foundation's Controversial New Cash

November 26, 2014 12:00 pm | by Ryan Bushey, Associate Editor | Comments

Concerns have been raised relating to a lucrative investment the Cystic Fibrosis Foundation made in a biotechnology company. Read more...                    


Mental Health Problems Increase Heart Disease Risk

November 20, 2014 9:42 am | by Cynthia Fox, Science Editor | Comments

People with mental health problems are “significantly” more likely to have stroke or heart disease, according to a study unveiled at a recent Canadian Cardiovascular Congress. Read more...


Maximizing the Power of Preclinical Cancer Research Tools

November 19, 2014 11:29 am | by Guizhong Liu, Senior Director of Cancer Biology, Crown Bioscience Inc. | Comments

Drug discovery is a protracted and uncertain process that needs to overcome many hurdles during preclinical and clinical development before it finally achieves regulatory approval for patient treatment. For every drug that reaches the marketplace, well over 100 have been abandoned at some point in their development. Read more...


Society for Neuroscience Annual Meeting Showcases Strides in Exploring the Brain

November 18, 2014 10:56 am | by Christina Jakubowski, Managing Editor, Bioscience Technology | Comments

More than 30,000 brain advocates from academia, industry and media converged on Washington, D.C. this week for the 44th annual meeting of the Society for Neuroscience (SfN). Read more...


Journal Watch: Top 100 Cited Papers of All Time

November 18, 2014 9:52 am | by Drug Discovery & Development Staff | Comments

In honor of the SCI’s 50th anniversary, the journal Nature asked Thomson Reuters for the 100 most highly cited papers of all time.  Read more...                                  


Going Purple: 5 Cutting-edge Breakthroughs in Alzheimer’s Research

November 17, 2014 9:03 am | by Christina Jakubowski, Managing Editor, Bioscience Technology | Comments

November is already halfway over— which means we’re also halfway through National Alzheimer's Disease Awareness Month, which celebrates and raises awareness for the nearly 5.4 million people who have this condition. Read more...


Glenn Beck's Health Struggle

November 14, 2014 12:53 pm | by Ryan Bushey, Associate Editor | Comments

The former Fox News anchor surprised his audience with some shocking news earlier this week. Read more...                          


When Tobacco Saved Lives

November 13, 2014 10:21 am | by Skip Derra | Comments

Will ZMapp’s Ebola success force big pharma to take plant-based drugs seriously? Read more...                                                      


The Odd Ouster of Sanofi's Former CEO

November 12, 2014 2:16 pm | by Ryan Bushey, Associate Editor | Comments

This high-flying pharma executive had his career derailed for a variety of surprising factors. Read more...                          


Fighting HIV with Stem Cells and Cutting-edge Genetics

November 11, 2014 10:51 am | by Cynthia Fox, Science Editor | Comments

“Berlin Patient” Timothy Brown was cured of HIV after he received stem cells from a patient naturally immune to the disease. His story inspired two companies to try and recreate that natural immunity in HIV patients using stem cells and two (then-new) gene-editing techniques. Read more...


Not to be Missed This Week: Journal Watch

November 7, 2014 4:48 pm | by Drug Discovery & Development Staff | Comments

Our editors searched for trending topics from leading scientific journals that will have you talking at the water cooler and sending them out via social media to friends and colleagues. Read more...               


Ebola Health Lessons: A Wake-up Call

November 6, 2014 12:02 pm | by Stephanie Guzowski, Editor | Comments

After months of delayed, fragmented responses, the international medical community recognized Ebola as a threat to global health security. Here’s where the situation stands today as well as questions raised and lessons learned. Read more… 


Google's Next Business Venture: The Human Body

November 4, 2014 2:07 pm | by Ryan Bushey, Associate Editor | Comments

Google is working on a slew of ambitious projects that could drastically revolutionize healthcare as we know it. Read more...                       


Using Real-World Data for Outcomes Research and Comparative Effectiveness Studies

November 4, 2014 10:17 am | by Christina Mack, Ph.D., MSPH, Associate Director, Epidemiology, Real-World & Late Phase Research, Quintiles, and Kathy Lang, Ph.D., Senior Director, Emerging Businesses Data & Analytics, Real-World & Late Phase Research, Quintiles | Comments

Biopharma is increasingly harnessing the power of data collected outside of a controlled clinical environment to generate valuable insights to support products throughout their lifecycle. Read more...


Regulatory Data: Vital for DDI Risk-Mitigation Efforts

November 3, 2014 11:04 am | by Philip MacLaughlin, Product Director, PharmaPendium, Elsevier | Comments

Unanticipated adverse drug-drug interactions (DDIs) have led to the withdrawal of several high-profile drugs that had been available for a number of years, including terfenadine, astemizole, cisapride, grepafloxacin and mibefradil.  Read more... 



You may login with either your assigned username or your e-mail address.
The password field is case sensitive.